Nutritional, Metabolic, Endocrine
Conditions
Interventions
low level laser therapy and hypoglycemic drug
hypoglycemic medications
Sponsors
dr Bassant Hamdy
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Type II Diabetes mellitus, started more than one year ago. • Both genders. • BMI from 25 kg/m2 to 39.9Kg/m2. • They receive medical therapy for diabetes one year or more ago. • Being clinically stable. • Glycated hemoglobin = 6.5 %. • Fasting blood glucose level > 126 mg/dl. • Two hour Postprandial blood glucose level = 200 mg/dl. .
Exclusion criteria
Exclusion criteria: • Patients with unstable glycemic control. • History of uncontrolled cardiovascular complications. • History of malignancy or hemorrhagic diseases. • Patients with a cardiac pacemaker or pregnant women. • Complete destruction of beta cell, (estimated from HOMA test (%B)). • Participants diagnosed with pre-diabetes, gestational diabetes, or type1 diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Measuring glycated hemoglobin (HbA1c): was recommended as an essential indicator for the monitoring of blood glucose control. The blood HbA1c = 6.5% was considered as diabetes; -Measuring fasting plasma Glucose level (FPG): There was eight hours fasting before test; -Measuring postprandial plasma Glucose level (PPPG): Two hour after eating from FPG test; -Measuring Fasting C peptide level: to detect level of: - acute effect of laser on glycemic control post sessions | — |
Secondary
| Measure | Time frame |
|---|---|
| Beta cell function (%B). • Insulin sensitivity (%S). • Insulin resistance (%IR). by using HOMA-IR calculator after measuring fasting blood glucose level, fasting C peptide. | — |
Countries
Egypt
Contacts
Public ContactHend Abd el moniem
assistant lecturer
Outcome results
None listed